Cases & Deals

ScinoPharm enters into strategic alliance with Baxter for generic oncology injectables

Clients ScinoPharm Taiwan, Ltd.

Jones Day advised ScinoPharm Taiwan, Ltd., a leading process R&D and API manufacturer with research and manufacturing facilities in both Taiwan and China, in a strategic alliance with Baxter International to develop, manufacture, and commercialize five injectable cancer drugs, with a current market of $4 billion, with an option to add an additional 15 injectable molecules. Baxter and ScinoPharm will collaborate on product development and manufacturing with Baxter having the right to commercialize the drugs.